                         ˿µϣ20051231գ

05.12.31, ¡ȡĴѧСڡȻ־ˡ
05.12.31, ޳³ҳܱҳ󡪡ӻ¼̸
05.12.31, ἱҹΣ١¼ľʾ
05.12.31, 淴߷Ӱо
05.12.31, ÿ켸硶ʦУѧ¼ı
05.12.31, ɽھմУѧѧΪйѧ»ᡷ
05.12.31, סйԺԺ롰ҵѧ¡
05.12.31, ԺЭϯҶԻԱҶ9
05.12.31, йܿUFOоѧжԶ
05.12.31, ʱزƷ
05.12.31, ϡҵ¡
05.12.31, ӱ
05.12.31, yw-yvesʵ
05.12.31, ϺĻ㱨ȵ㻰 չע

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ĴѧСڡȻ־
λƭҪNature Biotechnologyͬ͹ͬȨ



Ϊ200311·ڹϵıΪAn engineered multidomain 
bactericidal peptide as a model for targeted antibiotics against 
specific bacteriaһĵĹͬߣʽҪǹ
ƪĵΪǲһѧĵĹͬ
ߡ

֮еͨѶСʵҳʱPH-SAʵĹ
ԱҩЧߡ֮Щȱ֪Щڸķ
ǰ֪ԼƪĵĹͬߡҪǣΪǶӢ
׼ȷĶӢ£ͨѶС֪ǲӢģ
ȴ·ǰδ˵ĵݣ·Ҳû
Щ߽ͬ͹һͨѶPH-SAġ

ֱӵPH-SAȨĴ̩˿ع޹˾PRPHET˾
PH-SANATUREʵԽеʱPROPHETĿѧGEORGIAѧ
ʿǷ˸ĵݣǲ֪ԭǹͬһƪ
һڵķġ

߷PH-SAмߵԣǿ
ʵݶʾPH-SAֻAgrD1ġStaphylococcus aureus(MSSA
MRSAɫ)пԣȱAgrD1"
ϸûпԡǰĺժҪУصָ
PH-SAԱƤûпԡԴǿν
ԡĸݡ

ΪĵĹͬߣǶֿѧٸеΪƵ
PH-SAνġԡǸڵġPH-SAȨӵ߳ʣͨѶ
СǶ̶ȲͬУĴعҵоɵĶ
PH-SAҪҩЧѧ顱ǡǡ෴PH-SA޴Ƶ
֡ԡPH-SAҩЧѧ֤ʵPH-SAԵAgrD1
ϸǿҵĿԡPH-SAɱɫ(MSSA
MRSA)ҲɱƤ(MSSEMRSE)Եи
Ծ

2003315ռӸĴعҵоµġPH-SAҪҩЧ
ѧ顱ڰҳժ¼

(1)Ph-SAͼ/ֽϾ(MRSA)Ŀúǿ
MIC50ֵΪ16mg/LMIC50ֵ㣬ǿù1.5
200ù16001600ͷ1240Լ/
о(MSSA)ĿҲǿMICֵΪ0.5mg/Lǿ
ù48ͷ78ù640020050

	
(2)Ph-SAԼбƤ(MSSE)Ҳ˽ǿĿ
ԣMIC50ֵΪ0.5mg/LMIC50ֵ㣬ǿù48
ͷ39ù640010050

(3)Ph-SAAȺBȺͷһãMIC50
ֵΪ8mg/LMIC50ֵ㣬Ը־Ŀǿù3ͷ
20-620ù12-2003-126-400
	
(4) Ph-SAԾм
ĿԽMIC50ֵ64mg/L

(5) Ph-SAԸԾд󳦰ϣϾ׿ײϾ̼ͭ
˾˾θ˾ˮһԣ
MIC50ֱֵΪ321880.50.532mg/LԾǿֿ
ء

޿ɱ粵ʵĴعҵоҩЧѧ֤PH-SA
Կԣڹ󿯷ƪӢνԡͨѶ
ߵĶ׫

ڴɵʵõĵȫСڴʵһ
С֣NTCʵҡʵPH-SAйʽٴǰ
оҩЧѧ֡ͨѶСǶ̶ȵزͬ֪
2003315ĴعҵоߵġPH-SAҪҩЧѧ顱
ڡ

֮ЩҲһֱ֪PH-SAδﵽ90%ϵĴȣҲһֱ
ƪӢġʵϣڹ󿯷ĵǰڣ200310Ѯ
̩˹˾ҩҵ˾ҩоС䵰ױ
ķ⣬ȷPH-SAǿҵĿԿƱ
ŨùغĲ¡Сȴڸʵ࣬
ŪЩͬڵԱ

Ҳ֪˶PH-SAʵʵĽڹ󿯷ƪ
ƵܵסʵʵͬʱҲΪʲôڴġҪҩЧѧ
顱УPH-SA˺ȴԱԵиԾɱ
ȫڱƱмĸŨùغĲ¡ùزȥ
PH-SAκοԡҲ֪һѧ¼ܺ
Ĵ̩˿ع޹˾PRPHET˾ѯĴѧNATURE 
BIOTECHNOLOGYһģһĹܵǣȴ
ύ, Ϊûдڹ

֤Ѿ޿ɱ粵֤ʵƪӢƵνα
졣ġҪҩЧѧ顱漰ߵʱ֤˴Ƶݺ
ǿѧ٣ʵʵνġPH-SAΪǿȴ
ԵĿáΪӢϰڲ˽ݵ±˹ͬߡ
ףΪ˿ѧϣͬʱҲΪԼκϣ
ΪǲܳΪѧߵһɲ֣,ڴʽڹ
سAn engineered multidomain bactericidal peptide as a model 
for targeted antibiotics against specific bacteriaһĵ









    绪 ŷ




1)	PH-SAҪҩЧѧ顱, Ĵعҵо, 2003315
2)	PH-SAҪҩЧѧ顱, Ӣķ뱾
3) PH-SAҩѧо, ػҩҵŹ˾                     
              200521                        
4)  PH-SAҩѧо, Ӣķ뱾

                                              December 18, 2005
                                              
Editor in Chief
Nature Biotechnology
345 Park Avenue South
New York 
NY 10010-1707

Dear Mr. Editor in Chief:

As co-authors of the article entitled An engineered multidomain 
bactericidal peptide as a model for targeted antibiotics against 
specific bacteria, published in your journal on November 15, 2003, 
we are writing this letter to request that our names and co-authorship 
be officially withdrawn from this article.  We can not tolerate to be 
manipulated by the corresponding author, Mr. Xiao-Qing Qiu 
(corresponding author or Qiu) and remain a part of scientific 
fabrication.

We co-authors used to work at the corresponding authors lab and over 
the years either participated in PH-SA project or were involved in 
pharmaceutical efficacy studies on PH-SA. Some of us were informed by 
Mr. Qiu that our names would be printed on the article as co-authors, 
while some of us were not made aware we were co-authors prior to this 
article being published. More importantly, all of us have a limited 
ability with English and can not accurately read English very well. Mr. 
Qiu knows our language barrier and never explained to us the content 
of paper.  He also never explained to us how the corresponding authors 
presented PH-SA on this article, even after it was published.

Earlier this year, the legal owners of PH-SA, NTC Holding Ltd. of 
China (NTC), and Prophet Biopharmaceuticals, Inc, of USA 
(Prophet) started an investigation in to the existence of PH-SA.  
The scientific advisor for Prophet, Dr Lijun Zhao of University of 
Georgia, translated and explained the content of this article to us.  
Then is when we realized that we were co-authors to an article that 
presented PH-SA in a way that does not exist.  According to this 
article, the authors claimed PH-SA was engineered very highly 
specified and repeatedly stressed that all data indicated PH-SA would 
only kill the bacterial with pheromone receptor AgrD1 S. aureus (MSSA 
and MRSA), but would not kill bacterial lacking the pheromone receptor 
such as other staphylococcal species or other bacterial.  In their 
bolded summary, the authors pointed out specifically that PH-SA 
reacted not against Staphylococcus epidermidis or Streptococcus 
pneumoniae; in order to emphasis their specificity. 

We are shocked by this scientific fabrication because the 
specificity that the article claimed definitely does not exist. 
The results of an official pharmaceutical study on PH-SA 
(pharmaceutical Study or study report) are in fact contrary to 
the article.  In this study, PH-SA showed bactericidal activity not 
only against MSSA and MRSA, but also against Staphylococcus 
epidermidis and Streptococcus pneumoniae, and other bacterial 
including all gram negative strains tested in this study. This study 
was financed by the owner of Ph-SA, and conducted by National Sichuan 
Antibiotic Industrial Institute, Pharmacy Group of China. Mr. Qiu and 
the other six co-authors participated in this study. 

The following 5 conclusions are quoted from the official study report 
In Vitro and In Vivo of PH-SA Effect Comparison page 7 to 8 
(English translation page 8 to 9), sealed and issued by National 
Sichuan Antibiotic Industrial Institute, Pharmacy Group of China on 
March 15, 2003:

 (1) Ph-SA presented very strong bactericidal activity against 
Staphylococcus aureus MRSA. MIC50 was 16mg/L. Based upon MIC50 values, 
bactericidal activity of Ph-SA was 1.5 times higher than that of 
vancomycin, 200 times higher than that of ampicillin, 1600 times 
higher than that of penicillin, 1600 times higher than oxacillin, and 
1240 times higher than that of cephazolin. It also presented very 
strong bactericidal activity against MSSA.  MIC value was 0.5mg/L. Its 
activity was 48 times higher than that of vancomycin, 78 times higher 
than that of cephazolin, 6400 times higher than that of penicillin, 
200 times higher than that of ampicillin and 50 times higher than that 
of oxacillin.

(2) Ph-SA presented very strong bactericidal activity against 
Staphylococcus epidermidis MSSE. MIC50 was 0.5 mg/L. Based upon MIC50 
values, bactericidal activity of Ph-SA was 48 times higher than that 
of vancomycin, 100 times higher than that of ampicillin, 6400 times 
higher than that of penicillin, 50 times higher than oxacillin and 39 
times higher than that of cephazolin.

(3) Ph-SA presented certain bactericidal activities against pyogenic 
Streptococcus, Streptococcus aglactiae and Streptococcus pneumoniae. 
MIC50 values were 8 mg/L. Based upon MIC50 values, bactericidal 
activity of Ph-SA was three times higher than that of vancomycin, 3-12 
times higher than that of ampicillin, 12-200 times higher than that of 
penicillin, 6-400 times higher than oxacillin and 20-620 times higher 
than that of cephazolin.

(4) Ph-SA presented certain weak bactericidal activities against 
tested Gram-positive bacteria, such as other Staphylococci, 
Enterococci and Streptococci. All MIC50 values were larger than 64 
mg/L. 


(5) Ph-SA presented certain bactericidal activities against other 
Gram-negative bacteria, such as E.coli, Klebsiella pneumonia, 
Pseudomonas aeruginosa strains, Enterobacter cloacae, Citrobacter, 
Proteus, Acinetobacter and Aeromonas hydrophila. MIC50 values were 32
1880.50.5 and 32mg/L respectively. These activities were more 
effective than all control antibiotics.

The above conclusions presented in In Vitro and In Vivo of PH-SA 
Effect Comparison indisputably demonstrated that there is no such 
existing highly specific functional pheromonicin.  This strongly 
indicates that the article printed in Nature Biotechnology was a 
deliberate scientific forgery and completely fabricated by the 
corresponding authors.

All of the proteins used in this pharmaceutical study were produced by 
the corresponding author, Mr. Qiu, either from his Sichuan University 
lab, or in a lab which was jointly funded by NTC and the University.  
Mr. Qiu and all of us participated in this study and clearly knew 
about the existence of this final official report issued by National 
Sichuan Antibiotic Industrial Institute, Pharmacy Group of China on 
March 15, 2003.

Some of us began to realize Mr. Qius PH-SA never purified to 90% and 
suspected the accuracy of this Nature Biotechnology article. In fact, 
in October, 2003, just three weeks before the Nature Biotechnology 
article published, pharmaceuticals research institute of Tibet West 
China Pharmaceuticals Group Inc., a corroborator with NTC, questioned 
Mr. Qiu concerning his protein expression process and frankly 
expressed their suspicion that the bactericidal activity of PH-SA is 
caused by highly concentrated streptomycin sulfate remaining, not a 
functional protein. However Mr. Qiu just evaded this critical issue 
and continued to manipulate data to fool all related parties. 

We are told by NTC and Prophet that the results of the verification 
experiment on PH-SA by Tibet West China Pharmaceuticals Group Inc. did 
not identify any such identical and functional protein that this 
article claims existed. This verification experiment also explained 
why PH-SA showed completely no specificity but so strong bactericidal 
activity against almost all of bacterial including gram negative 
strains. It is streptomycin, not the authors so called 
pheromonicin that kills MSSA and MRSA. After the remaining 
streptomycin sulfate was removed from the pheromonicin samples they 
did not demonstrate any non-specific antibacterial activities. We are 
also told by NTC and Prophet that they inquired several times to 
Sichuan University, the seller of PH-SA requesting the identical and 
functional protein that was presented in the Nature Biotechnology 
article.  They never provided such protein because it has never existed.

All of the hard evidence indisputably proved this article published in 
your journal (in English) is a scientific fraud.  The Pharmaceutical 
Study Report demonstrates the data and invention that was 
presented in this article is scientific fabrication.  Because of our 
English barrier, we were misled by the corresponding authors to become 
co-authors of this article. For our own professional reputation, 
responsibility and moral principle, as well as the sake of the dignity 
of the scientific community, we request officially and publicly to 
withdraw our names and co-authorships from this article because we can 
not remain connected to this scientific fabrication.



Very Truly Yours,

Jun-Yong Zuo, Yang Li, Yu-Qi Zhou, Hai-Yun Wang, Su-Hua Zhang, 
Zheng-Rong Ou  


Enclosure:
   1) Pharmaceuticals Study Report: In Vitro and In Vivo of PH-SA 
Effect          Comparison, Chinese Version, sealed and issued by 
National Sichuan Antibiotic Industrial Institute, Pharmacy Group of 
China on March 15, 2003.

2)	Pharmaceuticals Study Report: In Vitro and In Vivo of PH-SA 
Effect Comparison, English Translation.
3)	Verification Experiment Report: The Summary of PH-SA Tests, 
sealed and issued by Tibet West China Pharmaceuticals Group, 
Incorporated on February 1, 2005.
4)	Verification Experiment Report: The Summary of PH-SA Tests, 
English Translation.

(XYS20051231)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ҳܱҳ
ӻ¼̸

ߣйѧԺԺʿ ޳³

ѧʱ 1230 

׶ѧϸרһڵ¼йط
ҷĵĲ˳֮Ѿ˺ȫȻ
ΪһѧңǺ׶ѧûвȡסʵ߽Ʊ
Ѿ֯˵ʵе顣ڵķչ
Ѿ֤ʵһ¼ں׶ѧȡʵȷ
ദ£˻⣬Ӱ쵽
Ĺ׶ѧѧĳŶȡ

2003귢ıʵҵٵĳ£ڱʵ
ҲҽҼҳ󣬲֯е飬ʵ󹫿ڹ
⿯Ϸģʵݵߡֻ
˸õλĳŶȣά˸õλѧ

ҹ˶١١Եȳ,Ǽټ
صλЩŽй鼰δ񱴶ʵһ׶ѧ
ȷԴЩ⣬Ǳ˼λڸĳ£ù
ҳ󲻿ΪݡӦʶ¶ҳĿľ
Ϊ˳ĳһˣĳһλǽ¶ĳĴԽˣ
ùѧȡѵԱ¼ظȱӦȷ
Դֻʶʾܸ󣬱һٷǰѺ
βˣҵһ硣ҳܽˣø
ȡѵ,άҹѧĳŶȡ»ëڵ
¡ҳ͵(Ϻձ927)дúãû
Ӻע⡣

һЩλҳԭ򣬲¼ҳӰ챾λ
Ǳĳһ֪ʵϣرֽ緢ʱ
סġƣ֮ڣڷڼҳȡֻ
ΪȫûʶλڸóŲȡ̣Ĭ̬
ȣʵϵЧãֻܶԸõλĳѧ𵽼
ӵãսֻܴʹƼҳĲϷ

ĳ֪ѧԷһ׮¼ദȷġ
ҲһЩ֮ͬһǣΪʲôĳ˽ദԴ
ǰ¼ȴŹšѧͬӦö
һƽȡԴ֪ӦϸҪҲᳫˣԹȥ
ĳЩ£ţ账Աû𵽽ã
ҲʶĴڱڸǵĳʵڲϴڸֻܶ
ѧ෴áĳ֪ѧ귢¼
ܲΪǹȥӴĺҲᳫˣҳ빫
¶˷ʥͣ޹£ֻҪʶͺãʶ
㣬˱ʶʾܴﵽǰ
β˵Ŀģܱٴη

ڱλҽҼҳ󣬻ⵥλҼҳĸˣӦΪǰĽ
󣬴Ӷҹѧʵвͬģ
Ӧù硣ܲȡ֮˻ʵؽƱ磬ܲ
ʵԽҷ˽áȴֻ
ܱʾ˻򱾵λܲϴȫûиľģֻܽһƻ
˻򱾵λѧ

ҹйصλܸҽҼҳе飬ʵ¸
ϴ󣬲Դάλѧܾҹѧ
ΧŤתҹǰѧ縯Ψһȷ 

(XYS20051231)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ἱҹΣ١¼ľʾ



֪ʶһѧ⣬ðαͽҪĵ
䷴--ʵǫѷ̬ȡ----ë(ʵ)
һнƻˣտѧ̬ȰµˣΪüƣΪܴ
ʵģûкý---- ë(ٵ)

ëһۣ֮ͬźܴķ
еУǿҵı֡ϵǸӵģһ˵ıҲǶ෽
ģڲͬʱҲһЩҲҪһǧ꣬ë
໰ȷǵ˲Ƶǡ

׶ѧίԱ23չ١¼鱨棬
֤ʵƳɹ11̥ϸϵȫǸƭ֡죬
һʱĺ¡ȷ桱Ǹ̴ְ һ֤
Ʋؼڡ١ΪʲôҪȥأϷձ25շ
һƪ¡¼享ἱ̬ úܺã͵
֮ڡ

Թ壬⣬ǿԼأѵ
Ͳ¾һҶ¼ҿءΪ
ﲻѧٵ⣬ȱȥ٣ˣҪ
һӡӵͺ˵ѧ谭й
ĿƼ£ǰ˶ɱйƼơ

øαѧⱣͿʹйĿѧĿƼ
£̹ˣ**񹦡ˮ͡ˮʲô 
ȫϢѧ֮ࡣҲ֪֧αѧУǹ֮ʿ
ϣйĿѧͼѸȣȻԿѧȱ˽⣬һЩ
˼Ͷαѧȱټ顣

ϮԣαѧЩԵŪٵΪҲΪ֮ѣ
ٰ㱣ϸ΢ĩڣԺ֮ࣻϰ˭Ҫ˲¶
δȨġ˽˴١йԣٵһλδĴ
ʦƣߵǷǣһڴˣ³Ѹ̣÷ϵķӦΪ
һ

̸ۣȴԱĳЩýҵԱΪ䱦ǲȥѧ
ĸܣȴڿ˼زϧƪȥԷѧܡ

лǲӦֵͲһֻռ˶ѡ

(XYS20051231)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

淴߷Ӱ

                Ժ

                     о
                               (2005)ֵ2181

    ԭƷңУ1 9 2 71 O1 2ճ壬ѧڣס
С5 2¥44 0 2š
    ίд˺㣬оʦϺʦ
    ίд
    ԭУ1 9 4 925ճ壬ʡʲʷ
оḱ᳤סлʹ궫2 9š
    ίд˺㡣
    ԭ·Ľ⣬У1 9 4 5 21ճ壬ձݸɲס
лʹ̩ɽ·33š
    ίд˺㡢
    ԭ֣ףУl 9 4 51 25ճ壬Һɻݸɲ
ס2 411 O 0 8ҡ
    ίд˺㡢
    ԭУ1 9 5 591 0ճ壬ʡʲʷ
оԱסӪׯ塣
    ίд˺㡢
    ԭŮ1 9 7 492 2ճ壬ϢѧԺְԱ
סСӪϢѧԺڶڡ
    ίд˺㡢

    淽()

    ίд**ʦʦ

    ԭƷҡ·Ľ⡢֣ס߱淽(
)ȨһԺɺͥͥ
ԭƷҡ·Ľ⡢֣סԼԭ֮ίд˺㣻
淽()֮ίдͥμϡսᡣ

    ԭƷҡ·Ľ⡢֣ס߳ƣ淽
()һûйעַġ˿վµ
ɷϸƵΪƼ١ԷΪ֯ڶࡰ
ڿ͡ü衢̰á˵¡淴Ĵƾ֤
зеģرУûпɱԣα϶ֻͨ
ֶΡһĹάȨ˾ȷйɣҲϹʹ
ԭ2 0 0 43³淢ˡڻӶʵһ飬޿
粵ʵ¶1 9 0 21 9 4 9䣬йս֮
֮ƣӶйƱһμʷվ
˴աĿｨˡ淴ƭ֡ררڣԷӵ
д£ת¹5 2ƪ¶⹥
ƭ֣ڻӶʵһǡƭ"
͵ӵġΪʲô˵淴Ǽٵġľĳġٵľ
ǼٵģαװӦȥǵġΪƭӱôԡ
Եġ淴һ׵׵ƭ֡ȵȡг˰
ڵʮһ˵ġ淴ڴƭֵĲߺ֧
ɿ಻˷áƭӣָרҡڡ
ʦооԱǵľáɼʧ˺
˿վණȨ룬Ѿӷ̰ǡ
ڿ͡ʱ׷ΡΪѹȨ
Ҫ󱻸淽ԭǸӰ죬⳥ʧ3 0Ԫ
⳥ʧ6 OԪϷá

    淽()ƣ˿վġȨ˵ȷݣ
˿¿صԭԸȨУ˿־İ
ȨΪ˿У˿ҳ͸ҳİȨΪ˿СðȨ˵
ʾ˿վṩ߲ұˣԭ桰淴
ǶԽ淴ļƾ֤ԼԽ淴¼ʵԵĿ
ۣԭȨ˸Ͻ𺦵֣˲
ɶԭȨԭġ淴ƾ֤α죬ؿ
αƱ֤飬˱Ӧֹ͹飬
ʵͬʱҪԽ淴ļƾ֤αм
ԭҵκʵͷݣԺöԭ
ߣͬʱԭȨұߵȨ

    2 0 0 42£ԭƷҵ࣬ԭ·Ľ
Ϊִ࣬ԭ֣סΪί༭ˡڻ
ʵ׷25ԪĻءһ顣鹲֣һֽ
зչſڶּ˻1 9 0 21 9 4 9
Ӷʷֽܡ淴ȥ淽񣬱
ϵ˿лĻĸ(ϵŷˣŦԼ
ע)2 0 0 45£˿վϷΪ淴
©һģΪ淴һƭ֡˵Ŀ
2 0 0 445գ˿վˡ淴ڴƭֵĲߺ֧
ԭ塣2 O 0 447¼䣬˿վ
ǡľĳ˵ġΪƭӱôԡ  ٵľ
ٵģαװӦȥһҲ淴¡淴
ʱʹˡƭӡ淴ǣǵƭֱʶƣ
ʱǾѵڡܱࡢ͡йԱ£¶ø
ĿʼԻߺͽ¶ƿڴˡԡ

    ͥУԭṩ˽淴ƾ֤Ƭ֤淴ʵĴڡ
Ŀǰйزδ϶淴ƾ֤ʵԡ

    ʵԭڻӶʵһ׷25Ԫ
Ļءһ顢˿վصķӡľĳ˵¡ԭṩĽ
ƾ֤(Ƭ)֤ݲڰ֤

    ԺΪ˿վϷġ淴ļ©
һĳԡ淴ļƾ֤ĿΪļ©ƾ֤ϵ
α죬Ӧ϶Ϊԡ淴¼ʵԵʶۣ
ûжԱԭȨ𺦵ݣ಻ԭ˸ܵ
ʵͥУԭṩ˿˿վľĳǵ˵
£ΪдڴԵֺԣ˶Ȩֺ
Ϊ˿վ쵥λ˿лĻĸˣȨӦɱ
淽еԴˣԺΪȨΪĺӦȨΪ˳е
ԭԷϵ˿վΪɣҪеȨ⳥ȱݣ
Ժ֧֡

    о£

    ԭƷҡ·Ľ⡢֣ס

    ѰʮԪԭƷҡ·Ľ⡢֣ס
(ѽ)

    粻ооʹ֮ʮڣԺݽ״
Է˵ڱеһмԺ

                              
                     Ա   Դ
                     Ա   ʥ
                     Ժӡ£  
                     OOʮ¶ʮձԭ˶
                         Ա   

(XYS20051231)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ΪĳδΪˣ漰ܷ׽ڵΪ

ʦУѧ¼ı

ߣÿ켸

(ǿУУͽѧĩٽʦĺܶ
ѧ¥ⶼȻУ԰ŵʱ
ѧĸУȴһѧԡУ

첦ͨʦѧУġСͨͲﴫ
ʮа˾ܶʼġһ򻨡Ĳ

Դӱ³վ˿ϣĲʵ֮
λſɹѧȨĴѧУһֱڷ籩ĵش

ȻѧίԱѧררңй̬ѧ¡йֲѧѧ
¡ʡѧλίԱίԱʡȻѧίԱίԱʡص
ѧƴͷˡƼͷΣļ15֮ࡣľ߷
ζǣֹ⻷ѧֶ֮γ˾޴ķ

֤дѧУҳϵġоɹУ4ƪ
ءݳƷֱ𷢱ڡֲѧ־̬ѧϵĶǳ
ͷβ֮

˵ԼһλLars Ericsonĺߣѧ1997
ڡֲѧ־ϷλLars Ericson2001о
ɹLars Ericson̬ѧϵģҪӢ
̬ѧ־ϲҵõƪλλ󷨡㻹
óƪڱһʵĸҲ

¼ع⣬ڰʦУ԰ͶһöذըԭѾƽ
У԰

϶ѡ

ʦѧλߺǰʡصУ֮һҲȫʡѧʦ
ҡûһϵ¼ɽˮΧǽƵУ԰
һͳ

Ȼں̵ܶʱУ¼ȫУ˽֪ݸУһ
λԸ͸¶Ľ˵Щ죬ӵĵ绰ͷģ
ʦҸһ¡ͨ绰Լ˼ȦķΧڣС
شʵġš

̫ˣƴһ𣬻Ҫѵ㹤㹤򶼲
ˣ˰رʾŭ

Сӣߣߣ۸ʦ˲ӢŶ
õûѧţѧ۸ֵйˡʦУĻ
ҵ㶪ˣ죬ƽߣһϽ̡ID
ƽ

Ͻ̡֪ܲӢ˶4ƪĵıҲѣ
мŲڡִӢ˫ʵ䡷в鲻ĵʣ㰴ⷭ
ҲڵеƪΪ벡Էֳݵ
Ӱ죨Impact of the flower smut Ustilago cynodontis (Ustilagiaceae) on 
the perfamance of the clonal grass Cynodon dactylon (Gramiveae) 
ԼֲȾΪֲȺƵӰ죨The effect 
of a vector-borne disease on the dynamics of natural plant populations 
for Ustilago violacea infection of Lychnis viscaria. EԵ
оƧǵ˸ڹȻС塱Ҫԭ

ȻͬУƺҲ٣

Ӧó˭򷽣ӣܣ

ٴӺζֻΪУѧϸ
ѡзЧ𣿡

ҳϵĲʵģԺʦѧѧԺͬ
ʱҲԺġʦͲŪˣ֪飬ԴԺԺӦ
𣻡ԡģһѧʦɵġʱ
ѧӦվϴ˵ʦ޹ء



4ƪӢı֮󣬴½ļз7ƪ
ƱSCIõĴ⡣֮11ƪĺ1Ĭ´ѧ
ġѧһϼʧˡ

£ѧУϽʦеͻȻΣ˵
һˡһλڰʦʮĽ˵

֪ʿ͸¶1992ѧɻعʱĲʿѧλ
⵽ɡ

ͬʱڸѧ˵ͶĬ´ѧ
UppsalaѧķУλڡҪ뱱Ȧ䱱ߵ½Ĭ´
ѧҳһ1965ĴѧǣAbout us
Ľ൱ԣǡѧֹĬ´ѧ־ѧ˳
ƺκһѧ

ұ乥격ʿѧλģʱ89չȥҸѧ
նģһԵģҪºѣҵĵʦΪϧ
Ƕ˽1ʱ䡣֪乥격ʿѧλһҪ6
ʱ䣬ҪڹѧڿϷ3ƪģȻٸ3ƪдһƪҵ
ġͬȥѧ˺ܶ࣬ʱ˶ѧɣ
Ϊô̵ʱõʿѧλ˵

߲鿴ļûзȡòʿѧλɵ3ƪ
ڹѧڿϵĵļ¼

꣬岩ʿѧλϼܲдţ
š

ʱ򣬸ϵôԶܵ
ȽѰɡڽ⳰

Ҫǣع֮ǰѾ硣֪ʿ͸¶ѧ
䣬ÿ¸ĸУʦУдһ⡰㱨˼롱ĳšع֮ǰ
ʡ쵼дţѧ֮ȭȭ֮ġ

ڡ顱ϡٵع֮󲻾þͱΪʦϵϵ
Ρʿѧ˶Ⱥԭϵϵε
λһ·УУ

2001٣У˵رУ֮ã
Ǵϵʦϲɼ걾һԼϵ
λʦ֣аʦǡʦ
£дԼȥϲɼ걾ıʦд
ġһȥϲɼ걾⼸λʦ绰ҶǸ
ûе¡ŭҪ״渱УУί棬Ұظ⼸λʦ
Ȱҡ԰ʦΪء²֮

飬Ӧú׵顣ΪֻҪһͰʦû
ϵͬרҵȨרɵĵ飬ɢ3죬Ϳ԰
ڶԵ߸̬ȣҲӦþȷд£
ôôٲʵܸ棬Ӧð޹߱
׷ܸߵķΡڱʼԸУ¼̬ʱ
ʦһλʦ˵

1213գڷϹеɵ10֮󣬼߲ͨ
Сͨ߱ݣҶ˵绰

ͬһ죬µ簲ʦѧίԱԱ֮һТڡڳԼ
ԡ¼֪顣ʣҲ˵УѧίԱỹ
ûаͨίԱÿһλԱûΪ˿ᣬԴ˽
кʵڵҳڼ䣬ʱֻǹػġⶼпܵģ
֪ɣ

֪ʿ͸¶ʡܲŻʡί֯ĸɲ
⣬ѧУȨʵġ漴µ簲ʡ͹ί칫
ңˡ

γƣ֪¡߱ʾ̽Ϣȥ
Ҫһ룬ڴ˺һʱ벻˽ռߡ
λʾҪʾʡļλͷڡͷǶ
ڣ漴ΰѼƸѧУѧУӦ˽ģϵһ
ѧУɡ

ߺɷڼ䣬βʦѧίԱΡʦУ
ڵİ칫绰źǣ绰һֱ˽߻ڲʿ
ָ㣬糿800֮ǰʦ¥Χ¡ճÿ춼Ҫʽ
֮ǰڰ칫¥һĹͷУ͸У1214գ
730糿830ʦλУ͸У칫ҵľŶرգ
֮κζ

ŷʮ죬ѧУʱûб̬ʦǿ⣬ܲ
ڸðɣʦĹѧУѧ˺ġڱ
ʼѧУ̬ȵĿʱʦһλʦ˵

ļǲԼдģʦԺһλԸ͸¶
ʿ˵ĿģǰʦǵļѧԺҳϡ
ɱṩʦļǹȥ֮ǰһ¡壩
УѧУ罨裬ѼύǣҲ
ⷽҪ󡣵Կ϶ǣļûڱӷ
ֵ4ƪĵģǲ֪4ƪʲôʱӽȥģ֪ǰ
Ӿסǲŷ֡

˶ﲻı׼

ʦһЩʦΪԡȷ£屾
Ʒȱݡ˼ԹȷΪѧٷΪ
ġ

޶żڡ¼֮ǰƶڲ۽
εġʦѧУڽ䷽Ѿðʦз

Уƣ׷ȫʮѧľ飬ʮ塣
һ̨̾⵽ȫУԺϵʦǵķԡ

÷䷽ڷΪABCУ涨ĿĿָ꣬
Aڡÿ5ԪBڡÿ3.5ԪĽ
Cڡÿ2ԪĽ

ӦָǣAڡ3ֹҼĿ1ʡĿ2
ҡ3ڹص㼰ڿϹһ4ƪڵ
ԼڿϹһ2ƪڵԼڿ
һ1ƪ͹صڿ2ƪBڡ3
֣Ŀ2ʡĿ1ҡ3
Ҽ1ڹҼصڿϷѧ2ƪڹҼصڿ
ѧ1ƪѧר1Cڡ3ƸڣڹҼ
ڿϷ3ƪģ110ϵרʡ
Ŀ1

ݿƹָ꾹ֵȺ鼤ܣ׷пܰ
ʦĴڶﲻCڵı׼һ׼˶ﲻ
׼϶ǲġʦһλжʮĿ׽˵ 

ΪʡƿĿҪԴһʡ
滮ĿһʡĿʡĿкܴһֵ
һЩȥʡĿҪ֡ƽ⡯磬й涨ֻ
صĿһĿøڡʦȡ

տ׽ṩ·ڰʡġսϣ
һƪʡ200477շġ걨2005ʡ
ѧоĿ֪֪ͨͨƣ2005갲ʡѧصĿ10
аָϹйƼѧĿ1

ʣµ8ĿҪȫʡʮҸУ֣ʦõһ
ʦġĿơ߰ʮڡͷ֣һڣ߰ʮ
ֵһʡĿ

ÿʡжĿ׽ģЩĿһ
ͨڶԣȹ׻ǻҪɼ

Ŀÿ궼УһһѧУ涨Ƹ3꣬
һλ3ֻ֮һȡĿĻᡣǽأ
ͷ֣һȡһʡĿҪ210굽240ꡣʡĿˣ
Ŀ͹ƹ滮ĿѶȿ֪

׽ίȣϵ۸ֱܣеìͷֱӶ
׼壺Ƹ3꣬޺Ҫ󣺽ʦ3귢10
ƪʡ£ۺϳ50з֡Уʦܲ븱ߣܲ
ߡҹ涨һڵְ޶ȥˡߣʵʵ
Ǹߣ58ѱʳʲôһڴѧһµ˶
ĵһУĳʶ֪ˣͷˡ
ĵٶǹˣĵ˵ٶǲģʦ
һ١

Ƕ֪Ŀô¡

ûܹﵽCڡAںBڵı׼أǿ϶
ġ

ļУ3귢3ƪѧĺ3ѧר
ҲڳеĶҼʡо⡣ͬʱλУ
Ⱥе9רҵεĽѧ

ⶨķ䷽ÿܹһ5Ԫ
ÿһƪSCISSCI¼Ļ6000ԪÿеһҼ
Ŀ3ԪĽÿеһʡĿ1ԪĽ

й˵ľ𣿡ѧУУʱ԰СʱΪλġ
ÿ쿪͸͹æģʱʵңһλԸ͸¶
֪ʿ۵壩ҲоǴûп
ϹΡϵġڿγ̡˼ҵӴ¡ʦԺһλ
˵

ҪĿ͡Ŀ¡ҪĿˣԼǲĿ
ġڡĿ˲ãһĿо򣬶ϰ򡣶ڹ
ҼĿһʡк͵λٰ1:1ıסЩǮжٽ
˵ʦ󾭼ϵһλʡ

Ƕ֪Ŀô£ҪĿҪǮһͨȥ
ĿѶȸУУԺȥ걨ǲһġʦѧԺһλ
˵

ڵĸУʦҪһץѧʣһץϵȨֻҪϵ/Ȩ
ֻӲѧʡֻûйϵϵλ˵ֻҪ
չԴĿĶ⡣෴ʲôûУͻѧʣ
㣬ҲʲôûС

ڰʦһ˵ڷΪ࣬춥ڡںͲ½ڡ
춥ָ֡˫ͬʱνѧָй㷺
ϵھӪ֮½ڣ˼壬ûȨûϵֽڻ
Ŀġ棬ֳ൱̶ȵĲࡣ

ڰʦѧԺҳϣһĹ桶Ժ4о
ȻѧΪ˵ġͭȾв°׳
Trifolium repens׳ݵUromyces trifolii-repentis
о24Ԫ3Ŀ˾ͬʱѧԺ
Ժϵְ

ڰʦҳϣһУ72005ȹȻѧ
ġϢʾȫУķΧڣ˫صĿı
ԺıҪСöࡣ7λĿУ2λѧԺԺϵ
ְλ5λǽѧͿһߵͨڡ

ʹǿرǿĿĽڣеĽ
ҲкܴΪĿһһ⣬ѧУ
Ƹ3ꡣҲ˵ʹһָAںBڵУ
3ֵ֮óбͲһԲҵĶ
һλԸ͸¶İʦ˵

еĵӦи˭ǲеĴѧҪΪоʹѧҪ
ѧУ¸ˣ

֪ʿ͸¶ʦľ߲ⶨԿΪӲָĽ䷽ʱ
Ҫ۾ǣʦѧ80Ŀйɲ15Ľʦ
ġ

֣밲ʦ½ġѧʹѧķչĿȣȻ
һľ롣ˣ˽䷽Ϊ75Ľʦʩѹ
еľٴ롣

˼ڵìǣѧУڷŽʽ൱̶Դ
ѧ롣

֮ǰʦһ4ڿξͿˣ֮ÿҪ810ڣ
ࡣʦһλ˵֮󣬰ʦʦʳֶȱһ
ЩݵĽڶƸѧУν̡

ʦͱ󡢸һѧУоͱı
ƽʦ󱾿ӷǳѧУй涨ڱѧһߣ
һűĿΣټоѧ൱һʦڳɵسеѧ
񡣰ⶨн׼һڿεĿʱ40Ǯȫ300ڿο
õ12ζһλʦÿҪ9ڿҡѧأ
ġ㵽Ŀôѣ£ʦܻ񽱣
λʦı£ѧУ⽱ǣѧУܳͷЩûдﵽָ
ʦΪҪ֪ЩǮڽѧһߵʦƴƴϴġһλ
Ը͸¶Ľ˵

ѧԽԽ顣ǰУȻҲġ
ĿЩֻܴ治ҹ֮󣬸УԴ
ԪѧУԴĴȨҲǰӴ˺ܶࡣ£ѧܵ
ǡߡʦ󾭼ϵһλ˵

ÿҼĿʱ򣬡С顯פʱ
ᴫĿŵؽôֱ׳˵ΪѧУѧƷչ
ڰһЩѧѧڿܱࡢ༭ǵļȼ٣һз
ȫ߻Իȡ쿯Ϊʦȡ
ķԭءʵ˼Ҫлǻᡮл쵼λ˵
Щƽʱ衢ƣ̸ѧʵˣȥ
ġѧߡܷƪġȥϿΣҲȥμۻᣬÿ
ڸѧѧڿı༭תƣϵҪĴǹ֡
ˣҲܵڡҸ˵Աרҵ˽⣬һ̿顣

ⲻǰʦһѧУ⣬ȫУձڵ⡣
˰ʦ֮֡λǿ

ڸߵȽģͬʱһѧΧ211
̡販ʿ㡢˶ʿ㡱˸ԺУͬķܶĿꡣðʦУ
쵼Ļ˵ѧҪչֻǽѧģ󣬶ˮƽ

211ʲô˲ʿ㡢˶ʿ㿴ʲôҲǿĺ͡Ŀ
𣿡ʦһλݽ˵ĵ־ļԽߡеĿļ
ԽߣϵռȨؾԽ󡣡

ǰǵĵڻῼǱʣ
ʵкܴƬԡѧиڣһ߰ʮƪıSCI
áû¾ʵ飬Իѧзóһݣֵģ
SCIˣݾרҵʿûκѧֵѧУ
ı׼SCIһƪ6000Ԫһ50򡣡ʦѧԺһ
λڶԸУձڵĲרҵϡĿϵĿϵ


±ƸΪ֮11ûз£ѧУ
¸ˣһڵ϶ûз롣λ
˵

(XYS20051231)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ɽھմУѧѧΪйѧ»

ߣ

ע˿עӵѧ١׶Σ˿վֽ¶
һУڵѧΪʦУڹȻѧ
ķ¼˷ڹڿϵĸĻԼ֣ͳ
ġ֪йѧѧܺʱˡգ˿վ
ǵķ㽭ѧ͡һѧѧ淶ݽ̸
ѧܵΣԼѧܡšѧҪ¡
źѧӦøѧܡʹһһ¡ҵ
һλͬйѧ£4Ѯݲμӵ޴
ѧ(FIMSA) ѧᣨ2005 4 18 22 գ֮ǰյ
ݴѧɽھݴѧУѧڵѧΪй
ѧ»ţͬʱ˶1ݴѧĽ
Ͷ⹫ţеĽһ⹫˿վѿǹ
xys.3322.org/xys/ebooks/others/science/dajia4/zhangxueguang2.txt
һ⹫δǣ2˿վϼƪѧѧܵı
xys.3322.org/xys/ebooks/others/science/dajia3/zhangxueguang.txt
xys.3322.org/xys/ebooks/others/science/dajia3/zhangxueguang3.txt
xys.3322.org/xys/ebooks/others/science/dajia4/zhangxueguang.txt
xys.3322.org/xys/ebooks/others/science/dajia5/zhangxueguang3.txtͬ
¸ҿЩ֮󲢸ңѧĿǰйѧĸ³
˽⣬йѧйЭĶѧ壬³Ǳѧ
ĳοԺʿйѧСϣѧҲܲȡһĴ
ʩʵҪѧҪ£Ҫйѧѧܡϣ
ѧڳο³Ĵ£йѧѧܲʱ¸ҵվ
ͷΪйѧһѧ˵ͬʱڴݴ
ѧԱܹվ˽Ĺڷѧܺѧѧ
ܵͨ˿վӳ渽йѧ»
ԼһδĹš

2005.12.29


ɽйѧ»ţ

йѧ³³͸λ£
Ǻã
20036£ݴѧйزź쵼ٱУѧڿ
Ū١ѧܣͬ11£ҽ˾ٱϼĸйѧ³
ָ³¡ݴѧҵľٱϺʵ󣬶2004
2£ѧŪٸѧһ½дУ
ܵĲţݴѧĿУδʵԵĴ
ڴϵĲλԺַ漰ѧѧܵ¼ѧ
վ˿վԴ˶бӱѧѧܣǽ
УʮǰУѧܣصġΪˣ
20045ݴѧѧίԱѧλίԱᷢ˹źͽ飬12
ٴη˹ţݴѧѧίԱѧλίԱᣬݽ20022
°䲼ڼǿѧ½ļݴѧѧ
裬ƶ̨ӦĹƶȣƶϱݴѧѧ½裬
淶ʦͿԱѧΪžѧܵķֽҵĹš
Լ˿վ϶ѧѧܵӦǣʹйѧ
ἰλ¶ѧѧܵĳΪнΪ˽⣬ϣѧ
ҲܲȡһĴʩͬʱҲݽڼǿѧ½
ļʵʱýнѧѧܽ
ع⡣ǴҹͬжΪѧѧܣƥ֮
ʹѧѧΪйѧйѧ׶֮ء

ݴѧҽѧϵ  
2005413

ɽݴѧѧίԱѧλίԱĹ

λίԱ
4µ׺5³дݴѧѧίԱѧλίԱĹ
ͽ飬ָ˸УѧڿĿŵŪٸѧܣΥ
й͵йѧѧ಻٣
¼ࣺŪ٣Լٽ֤ϣ걨Ƽͼƭȡѧ
ǿռʵҵģռʵҵĳɹΪƾ
ѧģܵԴޣͨĽߺϸ
ߵĻӦоȡشͻơѧѧܲǼ򵥵ĳϮ
֮ĵͲѧܣͨŪ٣ͼƭȡѧĸ߲ѧ
ܣѧܵʸΪӣӰҲѧѧ
Ϊܻѧµϡݴѧѧ
20022µġڼǿѧ½ļУҪ
ߵѧУйصλҪ߶ѧ½蹤ҪַѧУѧ
ίԱᡢѧλίԱѧڶѧǿѧ½
áȷҪѧ½䵽ʵѧͽ䴦ƶȡ
涨СΥѧ¡Ӱ켫ӵΪڳ˽ʵ
Ļϣͨýп͹۹ˣڹźͽ
УѧίԱѧλίԱݴѧѧ½裬ƶ̨
ѧ淶ѧµĹºƶϱݴѧѧ½裬
淶ݴѧʦѧΪžѧܵķʹݴѧڽ
ȷĵ·Ȳѧˮƽѧ
2002꣬ѧѧ¼ѧݽ
ļ͡ѧʦѧɹ淶ڽϺ
ѧϵദȥεѧְֹͣղʿμ
飩2004꣬ѧַ˻Ӣڵ¼ٴν
ĴƸ˻Ӣڣ2ѧ2004귢
ڵѧ¼νڡϲͼ·ͬ־
䳭Ϯʵ϶̬ȽϺáѧǶνڽϺѧ
ϵദǹֺֹͣʿоʦʸ2꣨3
ѧ͸ѧԱУѧ̻ܲؽд
ӮأΪУУšй
ѧԺԺʿʮַѧܵ޳³
ʵңλŵߣ2001귢ѧ٣α
ʵݣ¼ʱָΣʱʵҲǧټƵ
ڸǣ޷ڸʱǧټƵ跨ҽڣؾ跨ʵ
µӣǼ֯Բࡣ׺󹫿
ֵˣشġȫûӰ챴ʵҵţǡ
ǡ෴¶Ųദ˱ʵҵšʵ
ҽְ񡣣ѧʱ2003121ձ
ȻݴѧѧŪٸѧܵĴǵ
УֹܵĲţ޵ͺѧϵĴ֡մѧӡˡ
˵ʵϸǵӡݴѧӺ̻ѧѧ
ΪݴѧӺֻ̻ʵ䷴ص
ݴѧ1ڶѧĴλˡ
̱¼ķԭ͸ӺڣԶѧվ
˿վֱѧµŪ¼??оĽѧҲ޼
Ū٣1ݴѧѧλʦӦ
ÿԵĿγϣԾ͸ѧɼѧʵŪȫ
ڳصĽѧ¹ʡоǿѧоδҹҵ
ɵϣڡоڵŪ٣ҲӦѧܣ
һ͵ѧܡ͵ѧܣԶԳϮѧܶҹ
ҵΣҪҹѧʵоʦƣϣͨʦ
õѧоԴ̵ãоѧ
¡ѧõѧͷŪٸѧܡ
ݴѧѧĵʦܹΪʦоΪϸĿ
Ա
һѧѧͨһһĽʦڲиŬáѧ
һѧԣһҪѧܶڴѧ
ѧԣϵĶֻиȥܽ
ֻѧܣѧѧܹάʵصõߡѧǰ
ƽȣûлȨ˭ѧܣ˭ӦܵѧϵĴӦ
Ĵ֡
λίԱݽ20022ļҪ󣬼ǿݴѧѧ½衢
άݴѧѧʷԵǼϣǵľٶ
ݴѧʷϡϣ¸ҵسеʷΣ򱱾ѧ͸ѧѧ
ϰӦеãֹѧܡٴνǾƶ̨漰ѧ
淶ѧµĹºƶϱݴѧѧ½裬淶
ݴѧʦѧΪѧѧΪȫĵ飬
ݵʵ;ڣѧϽشԶѧ磬žѧ
ݴѧʹݴѧѧоܹչΪݴѧѧ
ĽѧάϹԵһʣҲΪݴѧʷǲ
ĥĹ

ݴѧҽѧϵ  
2004123

(XYS20051231)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

йԺԺ롰ҵѧ

 
人 ũҵѧ

˿վ1214׳صͽйԺԺԺ
ʿƶȲɶҡ1221ܿߺ׫дģԺʿѡй
ѧ磬ĸСģйѧԺվϵйر
Ժƺ׳ţԡйԺԺʿҲǿѧϵĿ
ģ¸ҵ˵Ŀǰϴڵѧѧ磬Ӱ
йԺ

Ϊա͵˵˵Ⱥ׳˾
һѧϵĿģԼͲŪΪ֪ġ
ֽʵ£˿վǳУϣõ
Ժָ̡

1987꣬йֿԺоԱ㽭ʡֳԱ
34ɼľϵΪϵΪǴɹʹ£
֯ƹ㡣ɼľҪ2530ܲɷɹ൱ڰ׶԰
43޼ΪƷ֣¡ֳƹ㡣һƵļ
ɹǣ㽭ʡ͹Ҵ󽱣ȫͶģȫ˴
ʮıۣӹڵ⣬ѧһ¹ϣһٳɹ
Դ۶ϲܷ2002612գ˿վ˱˵
йƼ֡ļȫ˴һģԴ˼Ҫ

ǣƼɹź͹ԱΪԼٵЩҪ
άٳɹʹ֪ˣҲҪάֽ־̨̨
ģƭӰΪӵģҪйѧġҵ
ѧ־ˣ־йԺԺ

2000꣬ڵ36ڡҵѧϷˡɼľϵ
Ŵƺѡ̽͡ɼľϵѡƪ¡¼ٽ
McKeandĹʽСұݵķó˵ɼ
ľϵѡ46ʱСͼԴ֤ǵĳɹǼٳ
·񽱽20ԪٴƸΪйѧľŴ
ίԱʡαʮԣġ֤ݺͽ۵Ҫ
£

1  ±㽭ʡֳ2֣1718
ɼľϵù̶ģͣȫ飬ظһ͵
ϵо봫ͳĹϵַһġϵֳ
һַϵ飬ƷֲſȷҪƷƹ㣬
µĵһ顣ȫּҹϵĳɼľ
ַΪ2530꣬ǵŽ1011꣬ˣǵδ
ɣƷδѡ

ǣǱܿϵĳһʽȥ㣬˵ѡ
ϵǴɹʹ¡Ǻ޸ݵģбһֿѧ񶨵Ķȴ
ֿѧϿɵĵ˵1718ϵǾԵġСȺ
塱ڴѡ510ϵǸСȺ塣ͳѧС
ۺŴѧŴƯԭСȺƽķģ
ûκιʽԤĲˣκιʽѡЧʺ䣬
û۸ݣɴ˵óһн۶α졣

2  ùʽŴѧеͨʽԷֳʱڼ
ϵѡŴġMcKeandжԴҲ˵úϵѡǽѡ
ĸڽʹ俪ʵʵѡ񣬵ȵȡ
ϵѡǴϵѡһЩϵѡϵԷֳ
ԷֳҪʹ俪ʵԣȫ
ͬѡ񷨡ŹƻľһԼ
ɵĹʽȥ㣬Ȳʵصݣˣ
ݺͽ۶α졣ΪоԱרңѵ֪ԷֳԷ
ֳ𣿲֪ϵѡϵѡǲα죿

3  νѡЧʣԷڵΪĸڵΪ
ӣȽõİٷǶ塣ˣ估Ӧǲٵġ
McKeandʽķš±˵ԴҲдúǵĻɷΪ25
ꡣɼľķΪ2530ꡣǣΪʹóѡ
СЩǾüķ䣨1011꣩м㣬óǼݺͼٽ
ۡùʽ㱾٣ֲʽҪṩУ
ԭ£ΪרҡоԱľŴרҵѧίԱ͹ʣͺ˵
Ū٣αݺͽˡѧ֮ڴˣαݺ
۵ķʹ˸еȿֿ̾ЦҲ;·ˣ

4  ϣѡϵ510
ʱŴƯƣЧΪԤ֪Ҳ


ѡǴȺ壬10002000ϵԤټ
跥ѡЧΪ1.0뷥ڵϵΪ0.3ѡ
ЧӦΪѡЧ0.09ǺСġ

ǣȴǸɵĹʽһٵƽѡЧ
ʣֵߴ1.24851.3554˵Ϊ׶԰
46ĶͯѡʿЧҪȴ2530ĳֱѡʿЧʻ
Ҫ24.85%35.54%ǿܵαҲ̫ˡ
ҪݺͽۣҲƭԡŵα졣Ǿ
ЩαۣΪԼĴ绤ƭҹƼ磬ƭҹҵ
߲ǵķ;ҵѧ༭Щ
ҵ¡

5  ʵϣǷпԿʽõѡ2
3ܾ꣬ƺʵţΪ46ꡣⷴӳ
αݺͽʱǳ㡣ùʽ㲻ǻӣȫ
ϣĽۡûһԿѧ̬ȡ

6  ڼϵѡʱҪСΪһ
ĸ䡱޽ӡʹ俪ʵ硣
McKeandжԴ˶˵úĻɵġ䡱Ϊ10ꡣ
ûЩûЩݣҲ£ǣǻ
˽Ҫʣα죬ǵڼϵѡ
ģ

7  ǵʹõǹ̶ģֻ͡2֣ÿֲַ17
18ϵϵǴȫ143ġǣȴ
ĽģʹһСĽ㷺ĴۣԼԤ
Ľ󲢽ƶ֮ñǣǵ㽭ĳСѧ
ѧѧɼ͵ó˵йСѧѧɼһĽһҲ
һα۵ķ

8  ǲǰ257ϵΪһƣǵÿִ
Լֻ20ϵÿָвͬϵˣ˵
MckeandʽĽѡ10ϵǴ
ѡģǴӿֳȫѡģ2346ʱ
ѡģǸһ꣨1011꣩ıֱ֣Ӵѡġ
ԼҲ˵ġԣǵѡMckeandʽɡ
Mckeandʽѡ䡱ǲʵ֮ʣѡǶ
޹صġûмֵݡMckeandʽĴ
ֻΪװģŪ飬ƭҹƼ

9 רҡȻ֪ʹ㷥Ϊ10
꣬Ҳǲ2346ʱѡ510ϵġһ
δᷢʱ뷨ԳЦɼľַһΪ2530꣬ô
2346ʱѡ510ϵأԵĴƾʶ
жϡ໹Ҫɷнµذһʽһȷ
£װɺܿѧⲻǰҹƼ͹Ⱥڵɵϼ
Ū

10 McKeandĹʽƪµĺ,һн۾ڴˡ
ûаѸùʽд, ԹʽеĲҲһֲᡣ
,һ仰  McKeand (1988)ĹʽѡЧ,ȷѡ
  ˽ᡣִҲʹ˻ɣ֪Լα죬
˲ȥоʽ

͵εġӵαͨҵѧ༭ˡ༭
ίԱᡢģ༭˵Щ¶󡢸󣬲
飬ǩֲŷ

200210£ȫѧģָ
òɵݣ벻ɵĹʽм㡱ȱҲ˽
ˣǴġԶԡҽĸ㡰ɼľϵѡ
ȶͶġҵѧҲδʹáα졯
ĵժҪǣ

2000꣬ڡҵѧϷƪ¡ͨ
ʽ㣬ó˵ɼľϵѡΪ46꣬Ϊʱѡ
ʱȷѡŵʻҪ24.85%35.54%Ǿݴѡ10
ϵѽ
ой׺֣˴ȺСȺĲ죬
ƽѡЧʵĸѼϵѡϵѡѹ̶ģ͵
ģʹòʵݽм㣬ùʽо
ɡˣɼľϵѡΪ46Ľûиݵĺ
ģҹҵصĴ

ҵѧ ༭ûָҵкδ󣬵ǣܾ
¡˵ܵ¡ڰ;ҹҵѧ
о󵼵⡱ҵпܶ
ߵĸɲӦеֺǽ˱ۡΪֻ
¶ñ˷ϰٻšټԭ򣬲άѧ־
ȴҪάߵ档

2004227գҵѧȻ˵ ༭δյġ
ɼľϵѡȶһģ˵
ǡմ𸴡Ժˡٴ𸴡

ǣĸ干ĳ4ݣΣÿݣֱйֿԺͱ
ҵѧǹҺżĳġʾֲѯ֤4ĸȫ༭ǩա
һŲѯִϻбҵѧշԱԣʣ˭˵ûյ
ʹ򣨹˵յˡ

ΪҪǣڴ֮ǰ200378գ༭žд

!616ռĳġɼľϵѡ
ȶһļѾյ༭Դ˷ǳӣ
ʱ˻㱨ҲյͬʱĳĲϡ 

ϸСҵѧ༭ͼ¡ 

ѧصʵͳšǣҵѧ޿κΣֻ
û

༭˵еĸ----󡭡󷢸ǰҪ
ǩ֡ףǽ
ϸĻ㱨Ǿǩֵġ

Ҳιйѧ³ٳɹʮ
Ϥ1989꣬Բ봦˰ǣ԰༭
ϸĻ㱨αԶӣǩ
֣䷢ôˣܹҹƼ˵һ


ԵˣᡣҲйԺ
ԺйԺרŵѧίԱᡣʵ֤
Ͳѧܣĳ䵱αߵİףɱѧһѧ
ϵĿģֵĿҲذٻšټԭ򣬷
ٵ£˷ߵñȿѧ־
ҹѧҪָܹ־ά棿

йѧΪ˲ⱣǲӦеóһЩ

(XYS20051231)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ЭϯҶԻԱҶ9

20051225Ժ

1222գʡмԺйЭϯҶһ
һо϶ҶַйЭԱƽȨоҶ⳥ƽ
ʧԪ

     йЭԱй黭ڴѧУУƽڣ
塷һ顣2004꣬Լ⵽˵ĳϮԡ12
£ƽмԺϳƣ20048£Ⱥڳ繫
ΪҶġֽ̼һ鲢ȫΧڷۡȫͳƣ
ֽ̼230ദϮԶƽ塷һ顣Ҷ
ֽ̼Ϯԡ塷طֻδ
塷еıУԴҲճҶȨʵԶ׼
֪ͼι˾沢ṫֺԭȨġֽ̼
һ飬ҲӦеȨΡƽԺֹͣȨΪͣ
ֹ桢ֽ̼ۡһ飬ȫеġձѧ
ϹǸӰ죬⳥ʧ80Ԫ

    ԶƽߣҶƣڴֽ̼һʱĶ˴
ϣа塷ʵزɷãȷ
塷ͬĵطȨβӦеΪڴʱ
ϸԭӰӹ˾ǩͬȷʾҷҶݼ׷ϸ
ԭӰӹ˾ҪдԼ׷ṩ漰֪ʶȨ⣬
ɼ׷ȫȨҷеΡ

    ΪȺڳΪԭƽͱҶ֮
ȨȨ֮粻ȨȨˣҶȨˡ̼
ΪȫϷġ

    ֪ͼ޹˾ƣ۵ͼϷĳ
ȺڳֱӽͼϹҹ涨ͼˣ
ù˾ûַԭƽȨ

     ԺΪԭԡ塷һȨӦ
ȨıУԱġֽ̼ԭƷбȶԣ
ԭɵĶԱȲпԿȷͬʵ
ı﷽ʽһδȨɶʹƷΪѾɶԭ
Ȩַ

    ڱϸԭӰĻĶĺͬеΪ
磬ԺΪϸԭӰĻĲǡ塷Ȩˣ
Ȩ˵ƷԼʶߵԼܳΪҶȨ
ɡҶΪɶԭȨַ

     ڶȺڳֻ鼮ĳ淢ߣڳ淢и֮ǰҶ
ͼͬҶƷȨҲӦı֤Ӧ϶
ȺڳѾע񡣶ڵ֪ͼǣԺΪ
۵Ȩ鼮ǾкϷԴĺϷֻӦеֹͣȨ鼮
ķΡ

    ΪˣԺоҶоЧֹ֮ͣԶƽ
塷һȨַڡԺϿԶƽǸ
ƽʧԪȺڳ֪ͼι˾о
Чֹ֮ͣԡֽ̼һĳ桢Сۣضƽ
 ߣ 

(XYS20051231)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

йܿUFOоѧжԶ

˹ٵйUFOǷǵۣսչΪ
ѧĽǷǼгΪܡ

̽9³ġ׽UFOᡱ֮󣬡UFOٴγΪһȴʡ

¼123»緢һƪͨѶƪпԺϽɽ
̨оԱ˼һ۵㣺98½ϿճֵĲ
ϿȷĽйء

ڶýٱһ¼;Уȷʾ˼۵ֻ
СƼ128տǵһƪ£ѧ߷ӡ

ԸǣУ֧˼ռϷ硣
ѧԡUFOˡ̬ȵ䵭γĶԱȡ

ųء

˼ڡʱһƪе9821ʱ3ң
ӼϷ³ľϺԼ³ľ½չ˾
ԱںϷڷеĲ壬巢Ž120
ȵΰ׹⣬ʱԼ10ӣɻ״͵״ﵱʱûʾ
ڡ

ͬʱﻹһοڵ
¼񣬿ʼʱ UFOֵͲһ淢55
ɵβʧݱ״ٷ򱱷
ֱʧ˵ʱĵĿ30λ

˼һҪǸβʧٶжϣ
и߶ȹ200ǧϣͬʱ80ϵŽ5
ͬжķΪһ
ŽǶС

⣬Ϊѧҵ˼ų˸÷ǵĿԣΪ
ȥԶݴˣ˼óۣųUFOǻ
йء

ڷ˼мҵġųϺ
̨ѧҸоԱָݡų׵õۣ
ңǡųҪֽ

߽һġUFO£1999꣬Ϻĳ
гһ״·߾ȽϹķáڿ
֣UFOΪԣ˵ʱĹ
׷ױʾȿųǷɻĿԣΪͨɻģ̫
ؾܵѯʱԸ̬

ӿʱ𣬸ͼΪǾһܷɻʱǰɷ
ļߺѯԱû̫Ļ󣬡
ʼ͸߶ȣҴӳϿշɹǶؿǾһܷɻ

ôʱΪʲôͿһܷɻųأ
ܸɵ̫ߡΧĹѧ⡢ԼͨͻȽϴйأ 
˵Ƶټ

һλѧҡԹ̨оԱһֿ
ܶʱǵ۾Լͨǵľǿסġ
Զ弰й켣ǿµֻڿеͶӰʱ
ǿһںŻطУʵпǳǻ
ٷСͬĵ۾ͷĴ80ȵ
ǣʵϿܸûô

ܡҲҪݡ

1213գϾձһƪ£˼ڴǿ˵ǡ
ܡûСȷˡ

븵Ϊʹ˵ܡ˵ķ
һãҲܼ򵥵ͨųõ

ֻƽ˲²Թ۵죬ͨ֡ųõһ
ܡĳν;Ϊһѧ۵㡢һĿѧ
ͱҵһ֤ݡ˵

˼һ۵㣬Ϊ½ġ
еķй켣ﷴŽǾݡ
Ϊֻһּ򵥵ġų(ųǵϵ)

˿ִܵ

˼ΪĹ۵ѧ缸òӦһҪԭ:ܶ
ѧҶΪ˼ִܵ

ڵ֮⣬Ƿ񻹿ܴĿǰڿѧû̫
顣ϣǿҵ:һĿǰѾ̫ϵ֮
ҵ160ϵ;ڶѧѾڶл
ļ󡣡 ˵ݻܻѭӼ򵥵ӡӵ
ȵߵȵĹɣѾݻ137꣬߼˵вӦ
Ωһġ˼˶ͬһ۵㡣

ǻǷпǼУһϣ˼Ĺ۵
λרо޴硣ĹݹݳʿԱʾ:˿
ڣϿΪǲ򡣡 븵ʾ
ִܵ򡱡

λרΪͨǼеִĿ΢΢Ҫǣ
ǼľڹۣоֹٶȲܴﵽ
߳١ǺߣٲɳԽԭǿѧչĲ
ţʱûзһԭǻǼΣȴһҪ
ơңһԭԽԽ֤֧֡

˼ΪǻԽҲʵǼС
100˴ڣһٵٶȷУԼ200Ϳ
ִ2000оǿܵġ ˼˵
Щ˿ִܵרңվִ˵Ͽ⣬
˵ļȫܱĿǰļȽǧ꣬ꡣ

ͬһ˵ǲڵļ̫Ϊʵ
ǼСΪ˼ִܵҪڶʶ
ȣţǶʶѾߵһ൱ĸ߶ȡΪ
ۣҪﵽ1/2٣ֻﵽ1/10(3ǧ/)ʵ
Ѿڵ졣

UFOоѧжԶ

Ϊ֪SETI(ڼѰˡ)ƻȣڡо
UFOҪҵమߣֶϿҲ㲻ǿѧоͬһ


SETIƻǣձڣҲõŲȷ
ʽϵˣΧѰи
ŲѰ롣

UFOѰ˼ǰǣѾ˵

ȻѰźһжѾŬ40꣬ҷȫ
˹ͬ룬ȻûѰҵȷ֤һ˿źš

߼˵˵ĵźšʺ򡯵ִĸӦԶԶ
ǵķִĸʡûյźţҲΪ˼
Ѿִһݡ˵ 

(XYS20051231)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

زƷ

2005-12-27ʱ

    زƷڶҵ̨ϹƣòƷܰȲβ
֬תƵزǡЧͼӰķزƷʹ
ȴӳκЧרָȲüƷķزƷûп
ѧݣ²ķա

    ʲô֤ʵְķزƷʵֻ
ԲˡġͨʳƷ

    Ͷ زƷ

    һʱ䣬Ůʿÿ춼ڵϿһ򡰲ľϸϡ
زƷ档Ҵ绰Ч˵ڵΣ3ͻ
ЧŮʿˣ8£600ԪǮһƳ(6ҩ)
ϸѯʦҪáŮʿ֣ҩԼزûг
α仯ҵļҲ˸òƷͬҲûڹЧ


    Ůʿ˵˵÷طѯ
ʦϵǺû˸Ҵ绰Ůʿ˵,ϵ
Էһӣ۹˾ַ͸¶

    زƷĵӹڶҵ̨淢ǡŷ
ӹġƣáHRTƷܰȲβ
֬תƵزĿǰͬƷСЧͼӰһӡķ
زƷκ䡢ߴ硢ʵĸŮá

    ûϵƷͿԸơ281Ա
˵

    ƣҪɷǸȣЧʿɴ98.9%ң
иٰ鷿ĹЧʼվܾ͸¶ŷ
ӹĵĵַǵĵַ˴壬Ϊڹ˾ҵǳæ
ֱӸʹҲܽӴ㡣

    ר زƷȱѧ

    ΥѧͽѧЭҽԺ
Ⱥ˵

    ǽڽܣ鷿ĴСԼصжйأһֲе
Ů鷿ƫСĻɾ֢Ȳ̬ͨѧķ
жȣֻͨѧоĿǰ϶û
취ϽʹмصķҩҲûõģΪ
ı仯ͨҩı䡣

    ͨڵ֬ԴﵽصЧŴѧʿ
ﻯѧרҷӶԴ˹۵ҲɡǴ֬˵
ͨԱƷҩܰ֬ĳطתƵ鷿ûκοѧ
ݣǷǳƵ˵

    кƴƼصĻѧʣԳЩֲƷܷء
˵ڻû֤ݱЩڻ̼ϸ󣬴Ӷ
ﵽصЧ

    ˵ʹüطأ޲ȴʹٰķա
ػŮԴӡ¾ȸá

    һ50ʹƷأǿ𣿡йط
ɣŷӹĸƷ۵αʾںܻӭ
ر󡣡ֻܸƷп˥ϵã溬ʲô
ɷ֣ȨǵĲƷһҪ򡣡

     ֻͨʳƷ

    ԱƣزƷ֤ͨҪûͨ
ƷǲеġڲزƷİװϣֻһ
֡š

    ŷӹĸƷ۵γϣδ֤ǿ
ǺõģƷҪԭܴ׼
ĺá

    ԱƣزƷǳҩģڳҩ
һ۷ֹ˾

    ҩʾòƷȷΪҩǴ
Ʒ䷽Ǹӹ۾Ͳˡ

    ֤ʵֻԳҩڷ̨ල
ţûйʳƷҩƷලֵţֻһͨʳƷ
ǱƷ

    ҵ Բˡ

    ղƷϵĽܣòƷƷΪһҽҩչ
޹˾ҽоԺ칫˵:ҽԺûһ׹˾

    ͨҩϵһ׹˾顣ƣƷ
ҽоԺĽзίгҩȻŷӹ
ۣԷֳɡϣڽʳƷǱƷǿ
һΪƷеκιΥҼɵΡң
ƷǳԲ˵ġƣһ׹˾ַڱҽоԺ
˵ҽоԺѵǹɶ֮һ

    򱱾ҽоԺѵ֤ѵ
ûκι˾û˵һҹ˾

    

    1993830չҹ֡15ŹġʳƷ
취ʮ涨ֹЧʳƷʮ涨ʳƷ
óҽҩƷԼ޷ÿ͹ָ۵

    ʳƷ淢й涨涨ʳƷ治úС¿ѧ
¼ȽӹաȾԻԻ߱ʾҲ涨
ʳƷ治óҩƷֱӻ߼ӵãҲ
ýĳЩɷʾ߰ʾʳƷá 

(XYS20051231)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ҵ



£(XYS20051230)ҵ¡ɺͲ
ɡۡƺΪҲӦöԳ½˵Ǿ䡰Ƕô
֪ʶרҵǰǲΥʶǷΥʶжϣ
зȨΪڴ˵ý壬ȻȨκκ
ɡ˵仰޴󡱡

Ȼľҵ¡˵½˵Ǿ仰
޴󡱣˼ΪýһɣǾɵɡ
Ȼ˵ĳһΪһɣϿΪȷġο
仰޴󡱺滹а䣬Ǿ˵½˵жϡҲ
ֵ

Ѿǰ˵ý壬߸һɣɿ
ΪɺͲɣҵĿģΪĳ
ɡΪĺҲӦ߸Գеͺñһŷ
ʧ̬ɣ/ҲҪеʧ̬Ϊĺ

Ȼ½˵䡰ý塭Ȩκκɡ̵ܷģ
Ϊ½˵ЩԺԺʿǡǡǲɣǽڻԶ
ǡʶϵģ½Ȱ֤Ķˡ

(XYS20051231)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ӱ



1223գ׶ѧ֤̥оɹĵί
Աṫ˽׶Եۣ϶٣귢ڡѧϵ
³١ںΪ6£身
λѧҡΪʹѧ缸С̡Ҳ
ʹѧߣѧʧʹޡ˹е𵴡

ڲǰйһͬƹѧӱȥ򱻳
ȫϢѧɱ󡰺ԩš1990һȫϢѧѧۻ
ڴָ"ԤԣȫϢѧ˵ӱڽŵ
ѧҽѧ90ӱӦʰ䷢ŵѧ
ҽѧĻ俨˹ҽѧԺȣھŵȨĽǵ
£ѧ档ʹݿƼͬ־˵ҹûκһƼɹܹ
ӱĳɹõŵѧҵۡľ
2005/02/28 йƼ籯--ɽרӱ庬ԩš »

һŪ֮Ϊȫ
Ȩġѧ롶Ȼ־ΪģڿѧҶԣӦ
ǵʥءЩΪͨ޴ӵ֪ġӱ
ڵЩԻͳɾֻһЩʿĿͷûõز
ʵͬ»ƪΪڹҿƼܲδԴ˿
϶ƼҲδչѧֻ֤α£199610³λ
Ժʿġαѧع⡷һ飬Ȼܵ"ȫϢѧ"һ¼
УԼķʽȫϢѧαѧ֮С

˵ǲ׼ȷġҶ֪ġλԺʿ֪Ǻ
ԺʿԺʿܳɷʱ˵ûд(ӱ)αѧ
£һɵģ޳³Ժʿġαѧع⡷
Ƽ¡ҽαѧһԭ򣺲(о)
ҵе飬ҶҪרҡ20051102 ų

ô޳³Ժʿεóһ۵أԼ1995꣬޳³ӵ
пԺת쵼ʾҪѧ֯רӱȫϢѧ
Ϊ޳³ѧѧίԱرһλ
ϢѧоѧίԱ޳³ĹУ䣬ʱר
һͨȫνȫϢѧϢѧרҲΪӱġȫϢ
Ϣۺ޹ϵ   νӦʰ䷢ŵѧҽѧ
俨˹ҽѧԺ޳³ΪרŵίԱҽѧѧ
дһźʵ£þյţӱKarolinskaҽѧԺı
治Ӧ棬ҹפʹƼģڱֻ˵һЩ
Ŀ׻ȫûƼΪŵѡ˵˼

ֱָӱȫϢѧαѧѧʿӣ
߷һλʱKarolinskaҽѧԺѧϰμӹӱ屨Ļ˽
дš˵ӱıȷʵѧԺ룬λߴΪѧԺ
ѧҲͨ˽˹ϵ赽ġϼйŵϣ
֮ǵαѧ顷WWW.JL.CNINFO.NET  2005-11-28 

ˣǶ¼Ӧ˱Ƚ˽⡣ѧð٣
ġǿ˹ģʱ俾ġĹ
ټȨģǱĿѧ罫һͷβѣ
һܺõӡ 

(XYS20051231)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ʵ

yw-yves

ˡǧݡŮʿļߴΪ֮ţУ
߳ĬеǷĿ´ʡ

Ȳ̸һˮ׼ѧˮ׼Ĺϵ֣ԭΪ
ڸߵд¥ϰϡľǰдʲô췽ҹ
̷ˡ

˵ʵҲʣĻУǾ;˼룬
һʹΪֻмܹΪȦǧ,
ɡ־Ծգս硱֮࣬Ҳ
ãڸѧˮ׼ȴδʲôЧ

ѩ˼ȷʵڼдˡⲢ
˵Խһܹдټӣ
лιһڵ¹˸ĸ¹ʾӡڷʾӺͰͶ
ʾӣͻ֪ʳǣԽдЩ
ġȻڼɡҲв٣ҵǶûйʾ
ɹǲιۣҲ˵ļʹţĪء
Щ˵ѧˮ׼֮䣬޹̶Ĺϵؼߵܽ
ΪƶȥͬۡҪԼʵ

ǧݡŮʿ⽫Լˮ׼ĳ̶
ĵƣеɵҲӦܹ⡣

(XYS20051231)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

ȵ㻰 չע

    /  

ϺĻ㱨2005.12.26-27

    ̵㣬Ƴýš¼㡭

    ؿ۲˼רԻʽ˵½¼
ɽԶС˵ǳ ÿһƪȫ깲40
ƪڶγɹк

    ֵý̵֮ʱԸýȫŻ̵㣬Ҫ
϶ߡ

    1

    Ϊ  ѧչϺע

    2005ũϦԲ֮ʱڹɽ¼ұ
ϲءСΪһ쵼ˣһƵƵ»
ƶʿ࣬˽顣ĺͶĻ⡣

    ԡũȻӡһҵũҵдũ塱
Ĳһӿ죬ũ˰ѸĸũƸĸʳͨƸĸ
²һ֡ũ塱ĻũȨ
̡

     ȫũҵ˰ȡũֲʵȺڿѡ
󡱣ʹƶͥĺӶѧ顱¼ұġᡱ
ڡʮһ塱ʱھᷢչ5ĿУֱ漰
ݾ3ռ͹̾ҵλӣᱣ
ϵȽϽȫƶ˿ڼ٣ˮƽձߣ
ˮƽȶסͨĻͻȷнϴ
ƣƽ;ȡ½չΰͰȫ״һ
תгȡ½

    2

    ѧǷϸ񡪡ɹ֮һ

    1026գۿƼѧѧýʾйϵľѧ
಻5

    2004ġɹ֮ڽ8˽˳Сһ
ͦˡѧ֮ʧԶѧĹ۵㣬ھѧ
ٴγĬá

    ֵġͦУжԹھѧҵ֮ѧ
Ѿѧ˵Ľ֮ףѧҰ̫ľΪĳһ
漯˵ý忪гһڹ漯еζµľѧ
ҵ˹ڵѧҡ

     ѧۡñ⵽˻ԺչоĸΡѧ
ʾѧ漴й۵ϣйѧҵĺϸʣ
뽫ѧ뷺µָֿ۾ѧоо
ĹףйѧΪռִѧ֪ʶŬܺӡ

    3

    ˲šڸУɰܵĴʦ֮

    ǷƶĽͩĿǰڵıƽģʽ
һ˲ţйѧĻˮƽѧ½

    漴ŵӦйѧúܳɹ

    һλѧʦһλ޽λ֪ѧ߶йĴѧ
ȫͬĿʦԣӿ

    й걨У԰ƵϵУ4802ͶƱ̬ͬʦ
۵Ĳˣռ2.1%޳ڹ۵ռ92.3%ڵȻ
ͩ

     ΪйߵȽ֮ܵɣշѸ߾ǰé⣬
ֵĸǸߵȽĹơ˵ֽйѧȱľ
֪ʶӵɥѧΧŨϢأ˳ɹ
쵼ҵ񣬵ȵȡУ׶ػΪУ԰ͻ
¼廪ѧڳµְ廪ѧʿѧѧԺ
ںͣоȡ

    Ӧͩ෴۵㣬ĺ֮ǮѧɭҲڲ֮
˽ԣйûȫչһҪԭûһѧܹ
ѧ˲ŵģʽȥѧûԼصĴµĶ
ðܳ˲šǺܴ⡣

    4

    ҽԺܷгӪҽƸĸʧܡĽ롰塱

    7£ԺչоᷢչоʾĿǰйҽ
ƸĸǲɹġһýһƬкһΪ
ܡкãΪҽгкá

    Դ˽ۣͬǴδ̬˵ҽƸĸﲻɹ
Ҳͬĸﲻɹ˵

    11 µףǿȫֳרѵϵĽ͸¶
ҽƷƸĸıҽƷɹ¢ϵľ档
ͨĸｫһֹҽƻƣٰ죬ΪȺṩͬ
ķвһҽԺӴͶ롢ϸתơ
ȷߣΪȺṩʡͼ۵ĻҽƷĹҽԺ

    ԴˣһֵҽĲɹȳ

    ƺΪʧۡעţ12ý嶶550ҽҩѡ¼
ɴ۶ҽƸĸɹڵȵҲۡҽƷѵš

    Ҳй۵ΪҽĲɹԭܶ࣬ΪҽĲɹг
ҽԴеãҽƸĸﲻɹҴӡйزź
Ҫ侲̬ܽʧϾĸһʯͷӡĹ̡

    5

    һ""Ƶ롰úϰ塱İ

    2005һꡱһݡ2005겿ֿбʾ17
ĺųؿѿʼһûһú󡰰ȫ¡

     ˷ָǣͷɵȨܵ漯ŵĵƣ3£з
ú˹ըڰಿ´֪ͨСʱ5£
ӱе¿ѣಿǰ´3֪ͣͨ飻ƵĿѽ껹ж
𣬶ڰಿ´֪֮ͣͨ󡣹Ұֱˡ
ӡ

    ΪŽֹ˷ۣúᡱڹɲ
ú֮󣬽1223գ4878ɲú5.6Ԫ

     ȻѲϣúϰ塱ȴɻ䣬һ³֣˾
̾զǡɽúϰһŹ20šڶԴ
ѵ̬ϣúϰ塱Ҳġ87չ㶫ѣúϰ塱
Ƹй3Ԫƽѵļƻ127պӱɽͿѣ128
һҹ֮ͽ2000Ԫɽпƽʻͳһ
ʹãεɡɽڣûաúϰԼĵֻҪ
ͲûǮ

    6

    Աơ̴ְ

    й칫Ժ칫122շͨɻشˮȾ¼
󣬹һֶܾ¼ӲԿܲغƲ㣬
¼ɵʧΡΪǣй롢Ժ׼

    2003귢ǵ䡱ԱƶȻ̴ְ
ҡȫ˴ίίԱݿΪ˵йƶ
ƣԱԽԽȫ

    Ҳй۵ʾ̴ְΪ̬ôȾ¼صһ
ԱӦ̡ƶ֮ƵĿѡҽĵʧܵҲӦйԱ̴
ְ

    Ϊܴϵ¶ƶʩȻźܴ
ɫʣͣڡϸ𡱣еƶԲȫҹ
ƶȽȻضԶ

    й۵ý쵼ɲְй涨ְΪ򹫴
ְԸ̴ְְְʽýΪ𵽡ЧӦ
йԱش¹ʴְһɽΪ̴ְ
ڡ

    7

    ҡۡȳ

     е롢Ժ꣬2005ĸǲ
ﵽ֮й500߼ֵƷơйƲƷйӪҵƷƾ
 50ǿй½ҵайƼайǿѧй
СйС㣬ȵȣȵȣһͷѡ
ʡиƵѡ䷢Э֯ѡý
ѡĿ࣬죬漰ҵ򣬷ĳ֡

    κθ˺͵λƺԴһһѡѡĹ
˼ලıȡĹߡˣȴСһ
ԸһԸġѡ߻ѡߵٿıҪг
гҪ˸

    ĲǮȴʹøָ꣬ҵƽ
̶ת޸ߡҪ淶žģ⣺˭߱
ʸ˭֤ල̣˭ල

    8

    Һս  춫ɽۡƽˮ󾭼

    1210գĿĶۡϺʺɽˮһڹ
̿,־ϺʺĽȡشͻƣΪӿȷǹ
ʺĵλƽҹɺ˴ǿ˸õĻ

     ɽˮһڹ̵ĽɣﳤƽˮĻ
ڽϣθõؿóƽˮʵӮչ
Ϊ˶شίԱעĽ㡣󿪷в𡢶ӿ췢
չĴ£ƽˮذʽʹ
Ϊҹ˷չ

    㽭ʡίίίǰ³ۼ޹˾ܲ
ܱͶϲɷŲɷʱʾ,Ϻʺĵ
Ҫɲ֣ķչƱؽɽʵƻͬЭ
趫ǹʺģŬΪǵĹٹӮס

    רΪ,ɽˮ۵ͬʱ󾭼á¡ͳƱ
2004꣬ҹҪҵֵܲΪ12841ԪֵΪ5268Ԫ൱ͬ
ڹֵ3.9%2010ңҹʹҵΪ񾭼õ
֧ҵ

    9

    еشٽչزг

    ¼ұڽȷҪƷز۸ǡʼ
ýΪ2005ꡰһϵеشʩͽءҡ
˽һ·ķزг

    3 17𣬸סʲŻݣϵ0.2ٷֵ㣻3
26գԺ칫·ʵȶס۸֪ͨаҪ
Ƿ죻428գԺ˼ǿزг͵صİ
ʩ511գ߸Ϸȶס۸
һ±ΪǱǰΪķشʩ107գ˰ַܾ
ʵʩز˰һ廯ɾ֪ͨٴǿȷˡ
ַױ뽻ɸ˰

    12ٿ뾭ùȷҽӾΪ
ص㣬ؿ͸ѻССС
УΪվáеĴֱָǣ棬غҾ
ƽС뾭ùǰһϵжΪ2006˾޴
ռ䡣

    2006ķزгơѧߺ߷ʿˡá
жϡȶס۸ѱΪ귿еصĿ⡣

     еѾȡ˽׶ԳɹزгͶʹ
ȡءһ̶ϵõ˶ơʾƷƽ
ۼ۸һȵǷΪ12.5%һΪ10.1%һ
8.8%ǰȷ۵ǷȲ̬ơ

    бָĿͶʹģƷۣٵͶ
ԤгֶΣйزڲн
˷

    10  ı걾塪˽ͨ°

    10 25գϺֶԺһ𰸼617磬
˿ᴩ·һĦгײڹ
»һʻĻҳѹ˲
϶ᴩΥҹ·ͨȫӦöͨ
ʸҪΡ

    ҹ˽ͨ°,ɴһ顣һΪ
·ϵġȺ塱ûаߡ̵ƵȹʩԴԽ·
ΪԹɡͨһΪ鶫Υͨ棬
شͨ¹ʲʹһΪѴҹ̷ӦԽͨ׷
Ρ

    רҶԴ˰ĸߣΪ˰б걾塣֮һǽ
˾ͬġͨΪˡĵλһͬʣʵˡڷǰ
ƽȡ͡йȨĹƽ

    11  ѧʴꡪѧƶؽ

    2000վѧѧ١ĹµӢ۷ӣ
ڸַУ־һЩý弰ߡսС
ܿսı̸źط֣ѧҡ

     ҹֵĵΣѧܲ޹ϵһЩУ
ͿлѧʹһЩʵѧѧܴ߱żһЩѧ
ܷȴ˫աпʵʹѧǲĿѧоԸԼ
ĴǷŵѧоϣҲѧžӪ˼ʹϵǧټƵ
ͶӪ

     ѧ߱ʾѧܻרң
ֱӻӵ𺦡ȨҪѧŻܡȥ귢
˺ųҹѧһѧ¡ġߵѧУѧѧоѧ
()ԸУѧѧоĻ淶ѧĹ淶ѧɹ
ѧ۹淶ѧ淶ȷĹ涨ΪȱӦĳͽ
ʩЧ΢

    12  ŮĻѧĻع顪ҵĻĻײ

     ӽ3¿ʼһɵġƽѡ㡱ϯȫŮ
Ļʳ˴ᣬް桶ʱܿķ档ӹ
ɣ ŮһɹҵԵгԷ
ġ𽥳֯Ϊ۹ỹ򣬶һ
ѧĹ⣬Ůȴ߱㹻Ĺԡ

    ⱻ߳ΪĻġŮ֮ʱΪĻ
ġѧҲڱпʼع顣

     йѧ˹ѧԺѧѧϵ˹ѧϰࡱ
ѧֲʽţ˹ѧ£Ͼѧ忪조
ˮࡱ˾ϾѧУķԶ;ֹ⣬ҲԻָѧ
壬˽ӡһϵеۺ飬ѧ2005꿪ʼȡ

    йѧУͱڽܲɷʱ˵ѧڽʵǸ˥΢
̡ҹ˶ѣñһ˵ļ׵ˡҪ
йҪسѧ

     ڹǷӦ񡰹ѧУйԺоԱ׫ָ
Ϊķչ仯һԵĹɣйҪֻ
ԼĻĻΪÿһĻĴɺ
߼˵˭˭ĻļֵԵġ

    ۽ΣϾˡѧѾʵռͱ
˵ؽѧ˹ѧһḶ́Ӧʵлʱ
ƣչ˱ۺ飬ʷ
飬С

    13  ʱǷҪʦʦ

    424գѧ߷Тͨ630գ鷨
ǣ1017գһѧ޽ͽԶ뿪ǡһ꣬λʦ̴
йĻ̫ĳʹ

    ʦţʹ֮࣬һʱҪʦ
һǡڸʦʱ

     й۵ΪڵĴʦ󶼲ڰǰǸʱǡ괫ͳĻֵ
ϵ߽Ļľ޴ҹĺܶѧƻڳ׶Σ͹ʹ
ܹʱռѧߵءʱһΰѧˣ
ά顢̫׵ȵȣһʱڲĴʦ

    Ϊڴתڼ䣬׷ǰ̬
ϵı׶ˣѧһЩۻƵȵȣ˲ŵķ
뷢չһײʦʱ

    пָ֮࣬ΪδĴʦṩõͿβ
һ˲ţǶԶȥĴʦõο塣

    14  ȡǡĸоѧԺԺʿѡ

    ȡСǽ»⣬ȥбУǺʾо
ѧȡԡšһ۵ģȻڹ
Ŀǰоѧƶȷ

     ۾ܶĿǰĿƶȶڸ֧ȡȴࡣձĹ
ΪĿǰоѧ֡塱ͨĹƽ
ȨһȡѸȨ·Ÿʦ乫ƽԺ˷ġ
й۵ΪĿǰУֱ׶ˣȡڼꡣ

    һȵԺԺʿѡǰֳһڡԺʿƶȴϡ
顣ʵϣ֮ǰҲѾ˷ѡԺʿȡԺʿƶȵĺ
һεļڲ

    ԺʿΪĿǰԺʿ̧̫ߣԶԶ˵Ժʿƶʱ
ġ֪ʶ˲šĳԣ顰ȡеԺʿƶȡй
ԺԺӦɣᶨرʾԺʿƶ볤ʱ俼
ȷģȻԣλɶҡ

    侲طۣʵٶСý峴ӰӣУ
ΪԶҪȡоѧԣȡԺʿǡҲֻ
ϣĸƶȵı׶ˡûҪȡԺʿƶȡ

(XYS20051231)

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)

һΪ˰޷˿վĹ˽˿վĶ̬ؿ
˿ʼбxys@yahoogroups.com

ʼбÿ췢һ˿վ¸µϣÿµ׷һÿ
Ŀ¼ʼбĶμ롰˿֮ѡ
ʼбxys_friends@yahoogroups.com

ù䶩ġù䣬ܿ޷յ
Ƽ䣺yahoo.com, hotmail.com, gmail.com

ġ˿ʼбĵ䷢һհż

xys-subscribe@yahoogroups.com 

塢ͣ˿ʼбͣ䷢һհż

xys-unsubscribe@yahoogroups.com 

Ͷxinyusi@yahoo.comôıļͶ塣

˿(www.xys.org)(xys.dxiong.com)(xys.3322.org)(xys.xlogit.com)
